No Picture
News

Karyopharm Announces XPOVIO® (selinexor) Data to be Presented at the European Hematology Association 2022 Hybrid Congress

NEWTON, Mass., May 12, 2022 /PRNewswire/ — Karyopharm Therapeutics Inc. (NASDAQ: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that initial data from a Phase 1 portion of the Ph 1/2 study evaluating selinexor in combination with… Click here to view original post… […]

No Picture
News

Ultivue Announces AI Partner Ecosystem to Accelerate Analysis of Multiplex Immunofluorescence Image Data in Translational Medicine

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Ultivue, Inc., an industry leader in multiplexing assays and analytics solutions for tissue biomarker studies, announced today multiple collaborations for AI-powered spatial phenomics solutions for translational research groups and Biopharma. Ultivue develops unique workflows for use in both multiplex immunofluorescence (mIF) imaging and spatial phenomics. Its proprietary InSituPlex®… Click here to view original post… […]

No Picture
News

Curis Announces Abstracts Accepted for Presentation at the European Hematology Association 2022 Congress (EHA)

Initial TakeAim Lymphoma combination data shows anti-cancer activity, including 1 complete response and 2 partial responses, in heavily pretreated patients including those with prior ibrutinib use LEXINGTON, Mass., May 12, 2022 /PRNewswire/ — Curis, Inc. (NASDAQ: CRIS), a biotechnology… Click here to view original post… […]

No Picture
News

Zambon Announces Attendance at American Thoracic Society (ATS) 2022 Annual Meeting

MILAN and BOSTON, May 12, 2022 /PRNewswire/ — Zambon, a multinational pharmaceutical company focused on innovating cure and care to improve people’s health and the quality of patients’ lives, today announced that the Company will attend the American Thoracic Society (ATS) 2022 Annual… Click here to view original post… […]

No Picture
News

BeiGene to Demonstrate Strength of Hematology Portfolio and Pipeline at European Hematology Association 2022 Congress

CAMBRIDGE, Mass., BEIJING & BASEL, Switzerland–(BUSINESS WIRE)—- $BGNE #BeiGene–BeiGene announced 20 presentations from the Company’s global clinical development programs in hematologic malignancies at EHA. Click here to view original post… […]

No Picture
News

CorEvitas, LLC and Inovalon Highlight Data Linkage Efficiencies at ISPOR

Panelists explore how connecting claims and clinical registry data lead to a better understanding of the patient journey WALTHAM, Mass. and BOWIE, Md., May 12, 2022 /PRNewswire/ — CorEvitas, LLC, the built-for-purpose provider of real-world evidence, and Inovalon, a leading provider of… Click here to view original post… […]

No Picture
News

Pulmatrix Announces First Quarter 2022 Financial Results and Provides Corporate Update

Ends Q1 with $47.5 million in cash and cash equivalents; Extends cash runway into Q2 2024 LEXINGTON, Mass., May 12, 2022 /PRNewswire/ — Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary and… Click here to view original post… […]